Mesoblast Limited (LWB) Financial Statements
Mesoblast Limited Financial Overview
Mesoblast Limited's market cap is currently $1.70B. The company's EPS TTM is $-0.04; its P/E ratio is -35.83; Mesoblast Limited is estimated to report earnings on March 4, 2027, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 122.89M | $ 17.20M | $ 5.90M | $ 7.50M | $ 10.21M |
| Gross Profit | $ 103.34M | $ 12.07M | $ -35.17M | $ -47.42M | $ -53.36M |
| Operating Income | $ -52.40M | $ -62.44M | $ -84.15M | $ -69.29M | $ -80.57M |
| EBITDA | $ -43.94M | $ -73.66M | $ -53.31M | $ -58.55M | $ -76.57M |
| Net Income | $ -58.76M | $ -102.14M | $ -87.96M | $ -81.89M | $ -91.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 47.39M | $ 161.16M | $ 62.56M | $ 70.92M | $ 60.03M |
| Total Assets | $ 773.08M | $ 784.68M | $ 669.15M | $ 669.41M | $ 662.14M |
| Total Debt | $ 127.33M | $ 128.16M | $ 118.92M | $ 116.50M | $ 106.91M |
| Net Debt | $ 79.94M | $ -33.00M | $ 56.36M | $ 45.58M | $ 46.87M |
| Total Liabilities | $ 204.67M | $ 187.24M | $ 188.80M | $ 167.58M | $ 165.10M |
| Stockholders' Equity | $ 568.40M | $ 597.44M | $ 480.36M | $ 501.84M | $ 497.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -44.73M | $ -50.68M | $ -48.79M | $ -63.58M | $ -66.01M |
| Operating Cash Flow | $ -43.83M | $ -49.95M | $ -48.46M | $ -63.27M | $ -65.78M |
| Investing Cash Flow | $ -1.02M | $ 120.00K | $ -97.00K | $ -194.00K | $ -232.00K |
| Financing Cash Flow | $ -15.33M | $ 147.34M | $ 40.25M | $ 74.50M | $ -9.87M |
Currency in USD